Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tension-Type Headache | 21 | 2024 | 76 | 8.340 |
Why?
|
Migraine Disorders | 37 | 2024 | 1693 | 6.560 |
Why?
|
Headache Disorders | 8 | 2024 | 148 | 2.450 |
Why?
|
Headache | 22 | 2024 | 1249 | 2.370 |
Why?
|
Neck Pain | 6 | 2024 | 186 | 1.830 |
Why?
|
Pain Threshold | 11 | 2023 | 600 | 1.500 |
Why?
|
Trigeminal Neuralgia | 2 | 2024 | 106 | 1.240 |
Why?
|
Post-Traumatic Headache | 7 | 2023 | 65 | 1.230 |
Why?
|
Hyperalgesia | 4 | 2023 | 530 | 0.950 |
Why?
|
Headache Disorders, Secondary | 2 | 2024 | 33 | 0.900 |
Why?
|
Tooth Loss | 1 | 2024 | 198 | 0.810 |
Why?
|
Pain Measurement | 6 | 2024 | 3514 | 0.760 |
Why?
|
Calcitonin Gene-Related Peptide | 3 | 2020 | 314 | 0.760 |
Why?
|
Vertigo | 1 | 2020 | 202 | 0.620 |
Why?
|
Disability Evaluation | 2 | 2024 | 1826 | 0.590 |
Why?
|
Analgesics | 7 | 2024 | 1066 | 0.590 |
Why?
|
Pain Perception | 2 | 2017 | 196 | 0.580 |
Why?
|
Dizziness | 1 | 2020 | 256 | 0.570 |
Why?
|
Central Nervous System Agents | 1 | 2017 | 75 | 0.560 |
Why?
|
Cluster Headache | 1 | 2017 | 54 | 0.560 |
Why?
|
Nutrition Surveys | 1 | 2024 | 1727 | 0.550 |
Why?
|
Pain, Intractable | 1 | 2016 | 132 | 0.510 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2016 | 448 | 0.470 |
Why?
|
Botulinum Toxins, Type A | 3 | 2022 | 229 | 0.440 |
Why?
|
Sensory System Agents | 1 | 2012 | 21 | 0.410 |
Why?
|
Cortical Spreading Depression | 3 | 2021 | 288 | 0.410 |
Why?
|
Neuralgia, Postherpetic | 1 | 2012 | 41 | 0.410 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2020 | 4547 | 0.400 |
Why?
|
Capsaicin | 1 | 2012 | 231 | 0.380 |
Why?
|
Depressive Disorder, Major | 2 | 2021 | 4735 | 0.380 |
Why?
|
International Classification of Diseases | 1 | 2016 | 884 | 0.380 |
Why?
|
Ketamine | 1 | 2016 | 516 | 0.360 |
Why?
|
Epilepsy | 2 | 2023 | 3267 | 0.360 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3159 | 0.350 |
Why?
|
Brain Concussion | 4 | 2022 | 1394 | 0.340 |
Why?
|
Tryptamines | 4 | 2024 | 93 | 0.340 |
Why?
|
Low Back Pain | 1 | 2018 | 979 | 0.330 |
Why?
|
Humans | 79 | 2024 | 760261 | 0.320 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2010 | 130 | 0.310 |
Why?
|
Spinal Puncture | 1 | 2010 | 281 | 0.310 |
Why?
|
Self Report | 3 | 2022 | 3707 | 0.300 |
Why?
|
Quality of Life | 8 | 2024 | 13300 | 0.290 |
Why?
|
Moyamoya Disease | 1 | 2009 | 255 | 0.270 |
Why?
|
Antibodies, Monoclonal | 3 | 2023 | 9196 | 0.260 |
Why?
|
Serotonin Receptor Agonists | 1 | 2006 | 151 | 0.250 |
Why?
|
Amitriptyline | 2 | 2010 | 112 | 0.250 |
Why?
|
Nociceptors | 4 | 2021 | 457 | 0.240 |
Why?
|
Muscle, Skeletal | 5 | 2015 | 4923 | 0.240 |
Why?
|
Comorbidity | 6 | 2024 | 10552 | 0.230 |
Why?
|
Population Surveillance | 1 | 2014 | 2609 | 0.220 |
Why?
|
Mastocytosis, Systemic | 1 | 2005 | 102 | 0.220 |
Why?
|
Carbamazepine | 1 | 2024 | 224 | 0.220 |
Why?
|
Vascular Headaches | 1 | 2023 | 21 | 0.220 |
Why?
|
Migraine with Aura | 3 | 2023 | 203 | 0.210 |
Why?
|
Serotonin | 2 | 2005 | 1041 | 0.210 |
Why?
|
Vasoconstrictor Agents | 1 | 2006 | 651 | 0.200 |
Why?
|
Adult | 28 | 2024 | 219847 | 0.200 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2024 | 220 | 0.200 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2022 | 42 | 0.200 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 25928 | 0.200 |
Why?
|
Female | 33 | 2024 | 391011 | 0.200 |
Why?
|
Migraine without Aura | 2 | 2013 | 82 | 0.190 |
Why?
|
Chronic Disease | 7 | 2024 | 9283 | 0.180 |
Why?
|
Middle Aged | 23 | 2024 | 220175 | 0.180 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2004 | 370 | 0.180 |
Why?
|
Whiplash Injuries | 1 | 2020 | 14 | 0.180 |
Why?
|
Nausea | 1 | 2023 | 677 | 0.180 |
Why?
|
Treatment Outcome | 12 | 2024 | 64947 | 0.180 |
Why?
|
Intracranial Hypotension | 2 | 2010 | 40 | 0.170 |
Why?
|
Prevalence | 8 | 2023 | 15687 | 0.170 |
Why?
|
Electric Stimulation Therapy | 2 | 2024 | 613 | 0.170 |
Why?
|
Depressive Disorder | 1 | 2012 | 3728 | 0.170 |
Why?
|
Double-Blind Method | 6 | 2024 | 12412 | 0.160 |
Why?
|
Comprehension | 1 | 2024 | 613 | 0.160 |
Why?
|
Vagus Nerve Stimulation | 1 | 2022 | 224 | 0.150 |
Why?
|
Headache Disorders, Primary | 1 | 2018 | 39 | 0.150 |
Why?
|
Male | 26 | 2024 | 359413 | 0.150 |
Why?
|
Meninges | 1 | 2019 | 197 | 0.150 |
Why?
|
Neuromuscular Agents | 1 | 2019 | 148 | 0.150 |
Why?
|
Neuralgia | 1 | 2022 | 597 | 0.130 |
Why?
|
Middle Cerebral Artery | 1 | 2017 | 275 | 0.130 |
Why?
|
Longitudinal Studies | 4 | 2022 | 14482 | 0.120 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2019 | 2282 | 0.120 |
Why?
|
Aged | 10 | 2024 | 168995 | 0.120 |
Why?
|
Relaxation Therapy | 1 | 2015 | 179 | 0.120 |
Why?
|
Pain | 4 | 2022 | 5066 | 0.110 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1067 | 0.110 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 1375 | 0.110 |
Why?
|
Skin | 2 | 2008 | 4468 | 0.100 |
Why?
|
United States | 6 | 2024 | 72363 | 0.100 |
Why?
|
Risk Factors | 9 | 2023 | 74269 | 0.100 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2235 | 0.100 |
Why?
|
Brain Infarction | 1 | 2013 | 292 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2022 | 3598 | 0.090 |
Why?
|
Adolescent | 7 | 2024 | 87747 | 0.090 |
Why?
|
Geriatric Assessment | 1 | 2018 | 1405 | 0.090 |
Why?
|
Cerebrospinal Fluid Pressure | 1 | 2010 | 38 | 0.090 |
Why?
|
Subarachnoid Space | 1 | 2010 | 81 | 0.090 |
Why?
|
Leukoencephalopathies | 1 | 2013 | 249 | 0.090 |
Why?
|
Administration, Topical | 1 | 2012 | 697 | 0.090 |
Why?
|
Prospective Studies | 4 | 2023 | 54263 | 0.090 |
Why?
|
Post-Dural Puncture Headache | 1 | 2010 | 53 | 0.080 |
Why?
|
Photophobia | 1 | 2009 | 71 | 0.080 |
Why?
|
Electric Stimulation | 2 | 2005 | 1735 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2880 | 0.080 |
Why?
|
Young Adult | 4 | 2024 | 58673 | 0.080 |
Why?
|
Health Policy | 1 | 2021 | 2678 | 0.080 |
Why?
|
Biomedical Research | 1 | 2023 | 3421 | 0.080 |
Why?
|
Incidence | 2 | 2023 | 21378 | 0.070 |
Why?
|
Mianserin | 1 | 2007 | 50 | 0.070 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2010 | 220 | 0.070 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2007 | 174 | 0.070 |
Why?
|
Cohort Studies | 4 | 2023 | 41317 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3005 | 0.070 |
Why?
|
Self Medication | 1 | 2006 | 117 | 0.060 |
Why?
|
Ibuprofen | 1 | 2007 | 229 | 0.060 |
Why?
|
Myofascial Pain Syndromes | 1 | 2005 | 37 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 3 | 2021 | 8157 | 0.060 |
Why?
|
Severity of Illness Index | 4 | 2012 | 15827 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4649 | 0.060 |
Why?
|
Spinal Nerves | 1 | 2024 | 91 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 2009 | 1272 | 0.060 |
Why?
|
Denmark | 1 | 2006 | 759 | 0.060 |
Why?
|
Physical Stimulation | 1 | 2005 | 518 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 12968 | 0.050 |
Why?
|
Societies, Medical | 2 | 2024 | 3903 | 0.050 |
Why?
|
Taiwan | 1 | 2023 | 503 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9945 | 0.050 |
Why?
|
Disabled Persons | 2 | 2022 | 1226 | 0.050 |
Why?
|
Citalopram | 1 | 2004 | 402 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7400 | 0.050 |
Why?
|
Child | 3 | 2024 | 79758 | 0.040 |
Why?
|
Logistic Models | 2 | 2012 | 13311 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10340 | 0.040 |
Why?
|
Leg | 1 | 2005 | 1091 | 0.040 |
Why?
|
Neuropeptides | 1 | 2005 | 941 | 0.040 |
Why?
|
Drug Combinations | 1 | 2006 | 2024 | 0.040 |
Why?
|
Rats | 3 | 2021 | 23695 | 0.040 |
Why?
|
Ketorolac | 1 | 2020 | 94 | 0.040 |
Why?
|
Head | 1 | 2005 | 922 | 0.040 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2019 | 97 | 0.040 |
Why?
|
Rodentia | 1 | 2020 | 260 | 0.040 |
Why?
|
Dilatation | 1 | 2020 | 307 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2012 | 15273 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2019 | 80301 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2061 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2003 | 2852 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2003 | 2932 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7468 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2007 | 6499 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2020 | 553 | 0.040 |
Why?
|
Propensity Score | 1 | 2023 | 1918 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2017 | 280 | 0.030 |
Why?
|
Arteries | 1 | 2020 | 1126 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1017 | 0.030 |
Why?
|
Body Mass Index | 1 | 2012 | 12901 | 0.030 |
Why?
|
Animals | 4 | 2021 | 167940 | 0.030 |
Why?
|
Forecasting | 1 | 2003 | 2931 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36247 | 0.030 |
Why?
|
Cost of Illness | 1 | 2024 | 1940 | 0.030 |
Why?
|
Nerve Block | 1 | 2020 | 686 | 0.030 |
Why?
|
Blood Platelets | 1 | 2004 | 2522 | 0.030 |
Why?
|
Dexamethasone | 1 | 2020 | 1928 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39254 | 0.030 |
Why?
|
Prognosis | 3 | 2010 | 29636 | 0.030 |
Why?
|
Piperidines | 1 | 2020 | 1650 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1718 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8553 | 0.020 |
Why?
|
Gene Expression | 1 | 2022 | 7592 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12532 | 0.020 |
Why?
|
Developing Countries | 1 | 2021 | 2880 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3929 | 0.020 |
Why?
|
Nitric Oxide Synthase | 1 | 2010 | 908 | 0.020 |
Why?
|
Iatrogenic Disease | 1 | 2010 | 538 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8449 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2731 | 0.020 |
Why?
|
Brain | 1 | 2013 | 26912 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 3327 | 0.020 |
Why?
|
Disease Progression | 2 | 2015 | 13505 | 0.020 |
Why?
|
Cognition | 1 | 2021 | 6948 | 0.010 |
Why?
|
Random Allocation | 1 | 2008 | 2394 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3762 | 0.010 |
Why?
|
Sensory Receptor Cells | 1 | 2008 | 509 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2008 | 1181 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10757 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16543 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22025 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8621 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10761 | 0.010 |
Why?
|
Treatment Failure | 1 | 2007 | 2646 | 0.010 |
Why?
|
Regression Analysis | 1 | 2008 | 6361 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2696 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10829 | 0.010 |
Why?
|
Sex Factors | 1 | 2008 | 10530 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81216 | 0.010 |
Why?
|
Depression | 1 | 2008 | 8033 | 0.000 |
Why?
|
Concepts
(196)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_